DIVI S LABORATORIES LTD vs SOLARA ACTIVE PHA SCI LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and SOLARA ACTIVE PHA SCI LTD (SOLARA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs SOLARA on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth10
  • Size & financial health40

Valuation

SOLARA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

94.49
P/E ratio
-1797.90
10.62
P/B ratio
1.65
0.33%
Dividend yield
0.49%
₹96.73
EPS
₹-2.05

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
-0.13%
22.00%
Return on capital
5.00%
33.00%
EBITDA margin
14.00%
24.32%
Net margin
-0.51%

Growth

DIVISLAB takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
-1.76%
12.10%
Profit CAGR (3Y) even

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.43L Cr
Market cap
₹2,574 Cr
₹10,560 Cr
Revenue
₹1,369 Cr
₹2,568 Cr
Net profit
₹-7 Cr
0.00
Debt / equity
0.51
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
SOLARA ACTIVE PHA SCI LTD
  • ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -3.27% over past five years.", "Company has a low return on equity of -12.0% over last 3 years.", "Promoters have pledged 37.1% of their holding."]
DIVI S LABORATORIES LTD full analysis SOLARA ACTIVE PHA SCI LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.